Short communication

The Impairment of Thyroid Hormones Homeostasis after Short-Term Exposure to Di(2-ethylhexyl)phthalate in Adolescent Male Rats

Sang-Yon Kim1https://orcid.org/0000-0003-1560-9153, Yeon-Pyo Hong1https://orcid.org/0000-0001-6375-1213, Yun-Jung Yang2,https://orcid.org/0000-0001-5461-1534
Author Information & Copyright
1Dept. of Preventive Medicine, College of Medicine, Chung-Ang University, Seoul 06974, Korea
2Dept. of Convergence Science, Catholic Kwandong University International St. Mary’s Hospital, Incheon 22711, Korea
Corresponding author Yun-Jung Yang, Dept. of Convergence Science, Catholic Kwandong University International St. Mary’s Hospital, Incheon 22711, Korea. Tel: +82-32-290-2795, E-mail: yangyj@ish.ac.kr

© Copyright 2021 The Korean Society of Developmental Biology. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creative-commons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Aug 10, 2021 ; Revised: Oct 08, 2021 ; Accepted: Nov 15, 2021

Published Online: Dec 31, 2021

Abstract

Di(2-ethylhexyl)phthalate (DEHP) could induce metabolic disorders through interfering with thyroid homeostasis. Therefore, we evaluated the effects of short term to environmental relevant doses of DEHP on thyroid hormones. Four week old Sprague-Dawley (SD) rats were treated with vehicle (corn oil), and DEHP 0.75, 7.5, and 150 mg/kg/day. The rats were treated with once daily by oral gavage and were sacrificed with after 1 week. They were measured body weight and relative thyroid weight, serum thyroid hormones and histological changes of thyroid. There was no difference in body weight between the control and DEHP exposed rats. Relative thyroid weight in DEHP 150 mg/kg/day treated group was significantly lower than control. Serum thyroxine levels was decreased in rats exposed to 0.75 and 150 mg/kg/day DEHP. No histological changes were observed in the thyroid of rats administered DEHP compared to control. Exposure to DEHP at environmental relevant levels, even short-term exposure, can cause hypothyroidism in adolescent rats even the exposure period is relative short.

Keywords: Di(2-ethylhexyl)phthalate; Thyroid hormones; Hypothyroidism; Short term; exposure

INTRODUCTION

Di(2-ethylhexyl)phthalate (DEHP) is one of the highest production chemical and ubiquitously present in environment because of the widely usage to improve flexibility in polyvinylchloride (PVC) such as building materials and medical products (Shelby, 2006). It can release into the environment from the products and enter human body through direct contact and use the consumer products. As a result, the general population is continuously exposed to DEHP through ingestion, inhalation and dermal absorption (Shelby, 2006). Although DEHP has relatively short half-lives and rapidly excreted through urine or feces (Koch et al., 2004; Frederiksen et al., 2007), DEHP and their metabolites were detected in various biological samples, including urine (Blount et al., 2000; Koch et al., 2006; Park et al., 2010), in serum (Silva et al., 2005), and in breast milk (Mortensen et al., 2005).

While most studies have been focused on the reproductive toxicity of DEHP exposure (Akingbemi et al., 2001; Park et al., 2002; Lyche et al., 2009), the plausible association between DEHP and metabolic disorders, including obesity, diabetes mellitus, and hepatic lipid accumulation has been raised (Gayathri et al., 2004; Martinelli et al., 2006; An et al., 2021). In epidemiological studies, the association has also been reported between phthalates levels and the occurrence of metabolic disorders, including abdominal obesity and insulin resistance (Stahlhut et al., 2007), and nonalcoholic fatty liver disease (Yang et al., 2021). It seems that DEHP could interfere with not only reproduction system but also the endocrine system.

Thyroid hormones which have an important role in regulation of the growth, metabolism, and energy homeostasis (Mullur et al., 2014). Thus, the development of metabolic disorders after DEHP exposure might be linked with the alterations of thyroid hormones. In DEHP treated animals, the histological alteration of thyroid gland and the changes of thyroid hormone levels were observed (Price et al., 1988; Gayathri et al., 2004). In addition, urinary phthalate metabolites levels was associated with the alteration of thyroid hormones in adults (Meeker et al., 2007). It seems that even small changes in thyroid homeostasis may induce adverse effects. However, experimental studies have been used relatively higher dosages of DEHP than the environmental relevant levels. As a result, some responses and effects of DEHP at environmental relevant levels on thyroid hormones still need to explain.

Therefore, this study focused on the influences that short term exposure to DEHP may contribute to the alteration of thyroid hormones in adolescent male rats.

MATERIALS AND METHODS

1. Animals and materials

Four week old Sprague-Dawley (SD) rats were used in this study. Specific pathogen-free (SPF) SD rats were purchased from the Charles River breeding laboratory (Wilmington, MA, USA). The rats were housed in an animal room controlled at 23±3°C with a relative humidity of 55±15% under a light/dark cycle of 12 h (light from 20:00 to 08:00 hours). All animals were provided with free access to water and an appropriate diet. After acclimatization to the light/dark cycle for 1 week, the experiment was started. The rats were randomly assigned to five groups (n=5/group), including control (vehicle) and DEHP 0.75, 7.5, 15, and 150 mg/kg/day treated groups. Dosing solution was prepared by thoroughly mixing DEHP in corn oil at the proper concentration. The rats were treated with once daily by oral gavage 1 week before being sacrificed. Dosing volumes were 10 mL/kg. The dosing solution was prepared by thoroughly mixing DEHP in corn oil at the proper concentration. This study was conducted in accordance with the Good Laboratory Practice (GLP) guidelines for Animal Experiments defined by the Korea Testing and Research Institute (TBH-1252, 2009/12).

2. Observed items
1) Body weight and relative thyroid weight

SD rats had their body weight measured 1, 3, and 7 days after treatment. The weight of the thyroid was measured after necropsy and then relative thyroid weight was calculated by thyroid weight (g) / body weight (g) × 100.

2) Thyroid hormone levels

Blood samples were obtained from the heart after sacrifice. The samples were kept at 5°C until centrifugation at 1000×g. Serum was distributed into sterile Cryo Vials (Greiner Labortechnik, Frickenhausen, Germany) in volumes of 500 μL and immediately frozen at −80°C until analysis. The levels of plasma thyroid hormones, including triiodothyronine (T3), thyroxine (T4), and thyroid stimulating hormone (TSH) were measured by enzyme-linked immunosorbent assay according to the manufacturer’s protocol (Endocrine Technology, Old Bridge, NJ, USA). The absorbance was measured 450 nm using a plate reader (Tecan Sunrise TW, Salzburg, Austria).

3) Histological observation

Thyroid was preserved and fixed in 10% neutral solution buffered with formalin, after which it was washed several times with ethanol (70%) before being embedded in paraffin. The embedded tissue was then sectioned at a thickness of 5 μm and then stained with Periodic Acid Schiff (PAS) and hematoxylin-eosin (H&E). Stained slides were analyzed by light microscopy (Olympus, Tokyo, Japan).

3. Data analysis

Data analysis was conducted using STATA (version 10.0, StataCorp LP, College Station, TX, USA). Statistical differences between the control and exposed groups were evaluated by the Wilcoxon rank sum test. p-value less than 0.05 were considered statistically significant.

RESULTS AND DISCUSSION

DEHP is widely used in plastic products to increase flexibility, thus, human can be exposed to DEHP through ingestion, inhalation, and absorption. It has been suggested that DEHP might associate with the development of metabolic disorders. Because thyroid hormones are important to regulate the glucose and lipid metabolism (Mullur et al., 2014), the alteration of circulating thyroid hormones due to DEHP might induce metabolic disorders through interfering with the binding of their receptors or transport proteins. Therefore, this study was conducted to identify thyroid hormones altered by short-term exposure to DEHP.

Thyroid hormones, T3 and T4 are released from thyroid gland, and are regulated by TSH in pituitary gland. When thyroid are not working properly, the circulating levels of thyroid hormones are altered and resulted in numerous disease occurrence, including cardiovascular disease, osteoporosis, and neurological function (Boelaert & Franklyn, 2005). Age, gender, BMI, family history of thyroid disease, smoking, estrogen, and pregnancy are known as risk factors of thyroid dysfunction. Recently, there is growing the considerable attention of DEHP on the development of poor thyroid function. The inverse association of urinary levels of DEHP metabolites with free serum T4 and T3 in men (Meeker et al., 2007) and with total T4 and free T4 in pregnant women (Huang et al., 2007) was previously reported. In animal studies, decreased plasma T4 levels were observed in rats fed with DEHP compared to the control (Howarth et al., 2001). In this study, after 1 week exposure to DEHP, there were no significant differences in body weights between control and DEHP treated groups (Fig. 1A). Relative thyroid weights significantly decreased in DEHP 150 mg/kg/day treated SD rats compared to the control rats (p=0.026) (Fig. 1B). In addition, exposure to DEHP 0.75 mg/kg/day and 150 mg/kg/day were significantly reduced serum T4 levels compared to the control group (p=0.015 and p=0.015, respectively [Table 1]). While serum TSH and T3 levels in serum were not detected the significant changes between control and DEHP treated groups.

dr-25-4-293-g1
Fig. 1. Growth and organ weights in control and DEHP treated groups (n=5/group). (A) Body weights and (B) relative liver weights were recorded. Data was showed mean and standard errors. DEHP, di(2-ethylhexyl)phthalate.
Download Original Figure
Table 1. The levels of thyroid hormones in serum between control and DEHP treated groups

DEHP, di(2-ethylhexyl)phthalate; TSH, thyroid stimulating hormone.

Items Control DEHP (mg/kg/day)
0.75 7.5 15 150
TSH (ng/mL) 1.01±0.09 0.89±0.12 0.94±0.14 1.02±0.14 0.79±0.08
T3 (ng/mL) 1.01±0.09 0.89±0.12 0.94±0.14 1.02±0.14 0.79±0.08
T4 (ng/mL) 57.86±10.69 24.50±12.13* 47.61±14.62 43.93±14.79 19.60±5.73*
Download Excel Table

In addition, previous studies have reported the histological alterations including increase of number and size of lysosomes, and hyperplasia after DEHP exposure (Price et al., 1988; Gayathri et al., 2004); while this study was not observed. It might be due to the relatively short-term of exposure (1 week) and low dose of DEHP (0.75, 7.5, 15, and 150 mg/kg/day). The treated dosages in this study were determined by considering the exposure levels of DEHP in general population (approximately 5-100 ug/kg of body weight) (Tickner et al., 2001) and in patients receiving haemodialysis and blood transfusion (up to 4 mg/kg body weight/day) (Calafat & McKee, 2006). Also, the highest dosage (150 mg/kg/day) of DEHP can reflect the obvious thyroid toxicity. Despite the histological changes resulted from DEHP exposure were not detected in this study (Fig. 2), short-term exposure of DEHP disrupt thyroid hormone homeostasis.

dr-25-4-293-g2
Fig. 2. Histological observations of thyroid tissue in control and DEHP treated groups (magnification: x400, hematoxylin and eosin stain). DEHP, di(2-ethylhexyl)phthalate.
Download Original Figure

The binding of DEHP to thyroid hormone receptors is suggested the underlying mechanism. The increase of iodide uptake after DEHP 10–4 and 10–3 M exposure were observed in FRTL-5 rat thyroid follicular cells (Wenzel et al., 2005). It might be due to the stimulation of sodium/iodide symporter (NIS) by DEHP in PC Cl3 rat thyroid cell line (Breous et al., 2005). However, adolescent male rats treated with DEHP 250, 500, and 750 mg/kg/day for 30 days were showed the decrease of thyroid hormone biosynthesis and NIS levels, and observed the follicular epithelial cell hypertrophy and hyperplasia (Liu et al., 2015). They suggested that the up-regulation of hepatic enzymes expression might reduce thyroid hormones. Thus, in order to evaluate the thyroid disrupting effects of DEHP, it is needed to consider the thyroid hormone levels, thyroid hormone synthesis-related proteins, deiodinases, receptors, and hepatic enzymes.

Consequently, short-term exposure to DEHP might lead the poor thyroid function at doses corresponding to transfusion of blood in a recipient. Further studies are needed to determine the long term exposure to DEHP.

Conflict of interests

The authors declare no potential conflict of interest.

Acknowledgements

This work has supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2021R1I1A3046386).

Authors’ contributions

Conceptualization: Kim SY, Hong YP.

Data curation: Yang YJ.

Formal analysis: Yang YJ.

Methodology: Kim SY.

Investigation: Kim SY.

Writing-original draft: Kim SY, Yang YJ.

Writing-review & editing: Hong YP, Yang YJ.

Ethics approval

This article does not require IRB/IACUC approval because there are no human and animal participants.

REFERENCES

1.

Akingbemi BT, Youker RT, Sottas CM, Ge R, Katz E, Klinefelter GR, Zirkin BR, Hardy MP. 2001; Modulation of rat Leydig cell steroidogenic function by di(2-ethylhexyl)phthalate. Biol Reprod. 65:1252-1259

2.

An SJ, Lee EJ, Jeong SH, Hong Y, Ahn S, Yang YJ. 2021; Perinatal exposure to di-(2-ethylhexyl) phthalate induces hepatic lipid accumulation mediated by diacylglycerol acyltransferase 1. Hum Exp Toxicol. 40:1698-1709

3.

Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ, Lucier GW, Jackson RJ, Brock JW. 2000; Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect. 108:979-982

4.

Boelaert K, Franklyn JA. 2005; Thyroid hormone in health and disease. J Endocrinol. 187:1-15

5.

Breous E, Wenzel A, Loos U. 2005; The promoter of the human sodium/iodide symporter responds to certain phthalate plasticisers. Mol Cell Endocrinol. 244:75-78

6.

Calafat AM, McKee RH. 2006; Integrating biomonitoring exposure data into the risk assessment process: Phthalates [diethyl phthalate and di(2-ethylhexyl) phthalate] as a case study. Environ Health Perspect. 114:1783-1789

7.

Frederiksen H, Skakkebaek NE, Andersson AM. 2007; Metabolism of phthalates in humans. Mol Nutr Food Res. 51:899-911

8.

Gayathri NS, Dhanya CR, Indu AR, Kurup PA. 2004; Changes in some hormones by low doses of di (2-ethyl hexyl) phthalate (DEHP), a commonly used plasticizer in PVC blood storage bags & medical tubing. Indian J Med Res. 119:139-144.

9.

Howarth JA, Price SC, Dobrota M, Kentish PA, Hinton RH. 2001; Effects on male rats of di-(2-ethylhexyl) phthalate and di-n-hexylphthalate administered alone or in combination. Toxicol Lett. 121:35-43

10.

Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC. 2007; Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 22:2715-2722

11.

Koch HM, Bolt HM, Angerer J. 2004; Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP. Arch Toxicol. 78:123-130

12.

Koch HM, Preuss R, Angerer J. 2006; Di(2-ethylhexyl)phthalate (DEHP): Human metabolism and internal exposure − an update and latest results. Int J Androl. 29:155-165

13.

Liu C, Zhao L, Wei L, Li L. 2015; DEHP reduces thyroid hormones via interacting with hormone synthesis-related proteins, deiodinases, transthyretin, receptors, and hepatic enzymes in rats. Environ Sci Pollut Res Int. 22:12711-12719

14.

Lyche JL, Gutleb AC, Bergman Å, Eriksen GS, Murk AJ, Ropstad E, Saunders M, Skaare JU. 2009; Reproductive and developmental toxicity of phthalates. J Toxicol Environ Health B Crit Rev. 12:225-249

15.

Martinelli MI, Mocchiutti NO, Bernal CA. 2006; Dietary di(2-ethylhexyl)phthalate-impaired glucose metabolism in experimental animals. Hum Exp Toxicol. 25:531-538

16.

Meeker JD, Calafat AM, Hauser R. 2007; Di(2-ethylhexyl) phthalate metabolites may alter thyroid hormone levels in men. Environ Health Perspect. 115:1029-1034

17.

Mortensen GK, Main KM, Andersson AM, Leffers H, Skakkebaek NE. 2005; Determination of phthalate monoesters in human milk, consumer milk, and infant formula by tandem mass spectrometry (LC–MS–MS). Anal Bioanal Chem. 382:1084-1092

18.

Mullur R, Liu YY, Brent GA. 2014; Thyroid hormone regulation of metabolism. Physiol Rev. 94:355-382

19.

Park MS, Yang YJ, Hong YP, Kim SY, Lee YP. 2010; Assessment of di (2-ethylhexyl) phthalate exposure by urinary metabolites as a function of sampling time. J Prev Med Public Health. 43:301-308

20.

Park YJ, Choi BS, Park JD, Hong YP. 2002; Age-dependent effect of metabolism and testicular toxicity to di(2-ethylhexyl) phthalate. Korean J Occup Environ Med. 14:236-246

21.

Price SC, Chescoe D, Grasso P, Wright M, Hinton RH. 1988; Alterations in the thyroids of rats treated for long periods with di-(2-ethylhexyl) phthalate or with hypolipidaemic agents. Toxicol Lett. 40:37-46

22.

Shelby MD. 2006 NTP-CERHR monograph on the potential human reproductive and developmental effects of di (2-ethylhexyl) phthalate (DEHP).Center for the Evaluation of Risks to Human Reproduction. Washington, DC: NIH Publication No. 06-4476.

23.

Silva MJ, Reidy JA, Samandar E, Herbert AR, Needham LL, Calafat AM. 2005; Detection of phthalate metabolites in human saliva. Arch Toxicol. 79:647-652

24.

Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. 2007; Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect. 115:876-882

25.

Tickner JA, Schettler T, Guidotti T, McCally M, Rossi M. 2001; Health risks posed by use of Di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: A critical review. Am J Ind Med. 39:100-111

26.

Wenzel A, Franz C, Breous E, Loos U. 2005; Modulation of iodide uptake by dialkyl phthalate plasticisers in FRTL-5 rat thyroid follicular cells. Mol Cell Endocrinol. 244:63-71

27.

Yang YJ, Kim T, Hong YP. 2021; Urinary phthalate levels associated with the risk of nonalcoholic fatty liver disease in adults: The Korean National Environmental Health Survey (KoNEHS) 2012–2014.. Int J Environ Res Public Health. 18:6035